S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
NYSE:INSP

Inspire Medical Systems (INSP) Stock Price, News & Analysis

$215.02
+1.52 (+0.71%)
(As of 03/28/2024 ET)
Today's Range
$214.00
$223.40
50-Day Range
$177.50
$226.00
52-Week Range
$123.27
$330.00
Volume
614,184 shs
Average Volume
393,982 shs
Market Capitalization
$6.52 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$271.29

Inspire Medical Systems MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.69 Rating Score
Upside/​Downside
26.2% Upside
$271.29 Price Target
Short Interest
Bearish
6.17% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.66
Upright™ Environmental Score
News Sentiment
0.39mentions of Inspire Medical Systems in the last 14 days
Based on 15 Articles This Week
Insider Trading
Selling Shares
$4 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.35) to $0.58 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.69 out of 5 stars

Medical Sector

68th out of 938 stocks

Surgical & Medical Instruments Industry

10th out of 96 stocks

INSP stock logo

About Inspire Medical Systems Stock (NYSE:INSP)

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

INSP Stock Price History

INSP Stock News Headlines

This AI Trade Machine Made 1,729%* (With 89% Wins)
What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:
Inspire Medical Systems (NYSE:INSP) Given Buy Rating at Mizuho
This AI Trade Machine Made 1,729%* (With 89% Wins)
What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:
Leerink Partners Remains a Hold on Inspire Medical Systems (INSP)
INSP Apr 2024 150.000 call
Edifecs to Speak at RISE National 2024
No waiting line for vets' care
INSP Jan 2025 185.000 call
INSP Dec 2024 135.000 put
See More Headlines
Receive INSP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inspire Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/06/2024
Today
3/29/2024
Next Earnings (Estimated)
5/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Fax
N/A
Employees
1,011
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$271.29
High Stock Price Target
$371.00
Low Stock Price Target
$159.00
Potential Upside/Downside
+26.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.69
Research Coverage
13 Analysts

Profitability

Net Income
$-21,150,000.00
Pretax Margin
-3.19%

Debt

Sales & Book Value

Annual Sales
$624.80 million
Book Value
$19.39 per share

Miscellaneous

Free Float
29,055,000
Market Cap
$6.52 billion
Optionable
Optionable
Beta
1.35
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

INSP Stock Analysis - Frequently Asked Questions

Should I buy or sell Inspire Medical Systems stock right now?

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Inspire Medical Systems in the last twelve months. There are currently 4 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" INSP shares.
View INSP analyst ratings
or view top-rated stocks.

What is Inspire Medical Systems' stock price target for 2024?

13 Wall Street analysts have issued 1 year target prices for Inspire Medical Systems' shares. Their INSP share price targets range from $159.00 to $371.00. On average, they expect the company's stock price to reach $271.29 in the next twelve months. This suggests a possible upside of 26.2% from the stock's current price.
View analysts price targets for INSP
or view top-rated stocks among Wall Street analysts.

How have INSP shares performed in 2024?

Inspire Medical Systems' stock was trading at $203.43 at the beginning of 2024. Since then, INSP shares have increased by 5.7% and is now trading at $215.02.
View the best growth stocks for 2024 here
.

Are investors shorting Inspire Medical Systems?

Inspire Medical Systems saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 1,870,000 shares, an increase of 6.9% from the February 29th total of 1,750,000 shares. Based on an average daily volume of 512,300 shares, the days-to-cover ratio is currently 3.7 days.
View Inspire Medical Systems' Short Interest
.

When is Inspire Medical Systems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our INSP earnings forecast
.

How were Inspire Medical Systems' earnings last quarter?

Inspire Medical Systems, Inc. (NYSE:INSP) posted its quarterly earnings data on Tuesday, February, 6th. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.53. The firm had revenue of $192.51 million for the quarter, compared to analysts' expectations of $186.75 million. Inspire Medical Systems had a negative trailing twelve-month return on equity of 3.93% and a negative net margin of 3.39%. Inspire Medical Systems's quarterly revenue was up 39.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.10 EPS.

What guidance has Inspire Medical Systems issued on next quarter's earnings?

Inspire Medical Systems updated its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $775.0 million-$785.0 million, compared to the consensus revenue estimate of $780.3 million.

What is Tim Herbert's approval rating as Inspire Medical Systems' CEO?

2 employees have rated Inspire Medical Systems Chief Executive Officer Tim Herbert on Glassdoor.com. Tim Herbert has an approval rating of 100% among the company's employees. This puts Tim Herbert in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Inspire Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inspire Medical Systems investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Cisco Systems (CSCO), Bank of America (BAC), DocuSign (DOCU), Pfizer (PFE), Block (SQ), Zynga (ZNGA), CrowdStrike (CRWD) and Johnson & Johnson (JNJ).

When did Inspire Medical Systems IPO?

Inspire Medical Systems (INSP) raised $75 million in an IPO on Thursday, May 3rd 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs served as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers.

Who are Inspire Medical Systems' major shareholders?

Inspire Medical Systems' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (9.91%), Vanguard Group Inc. (9.91%), Wellington Management Group LLP (4.84%), Baillie Gifford & Co. (4.17%), Wasatch Advisors LP (3.71%) and Frontier Capital Management Co. LLC (2.51%). Insiders that own company stock include Georgia Melenikiotou, Jerry C Griffin, John Rondoni, Marilyn C Nelson, Philip Ebeling, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert.
View institutional ownership trends
.

How do I buy shares of Inspire Medical Systems?

Shares of INSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:INSP) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners